A global, phase 2 study of ARX788 in patients with HER2-positive metastatic breast cancer whose disease is resistant or refractory to T-DM1, and/or T-DXd, and/or tucatinib-containing regimensJanice Lu,Kevin M. Kalinsky,Debu Tripathy,George W. Sledge,William Gradishar,Ruth O'Regan,Joyce O'Shaughnessy,Shanu Modi,Joshua Drago,Haeseong Park,Amelia McCartney,Sophia Frentzas,Catherine Shannon,Katharine Cuff,Richard Eek,Miguel Idzwan Martin,Giuseppe Curigliano,Guy Jerusalem,Chiun-Sheng Huang,Michael Press,Matt Li,Dong Xu,Cynthia Song, Richard Huhn,Jinchun Yan,Sara HurvitzCANCER RESEARCH（2022）引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
